JP2002527470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002527470A5 JP2002527470A5 JP2000576834A JP2000576834A JP2002527470A5 JP 2002527470 A5 JP2002527470 A5 JP 2002527470A5 JP 2000576834 A JP2000576834 A JP 2000576834A JP 2000576834 A JP2000576834 A JP 2000576834A JP 2002527470 A5 JP2002527470 A5 JP 2002527470A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- formulation
- alkyl
- hydrogen
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 208000007848 Alcoholism Diseases 0.000 claims 1
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 125000002009 alkene group Chemical group 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 231100000572 poisoning Toxicity 0.000 claims 1
- 230000000607 poisoning effect Effects 0.000 claims 1
- 229960004394 topiramate Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10488798P | 1998-10-20 | 1998-10-20 | |
| US60/104,887 | 1998-10-20 | ||
| PCT/US1999/023769 WO2000023059A2 (en) | 1998-10-20 | 1999-10-18 | Use of anticonvulsant derivatives for treating alcohol dependency |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002527470A JP2002527470A (ja) | 2002-08-27 |
| JP2002527470A5 true JP2002527470A5 (https=) | 2005-08-25 |
Family
ID=22302937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000576834A Pending JP2002527470A (ja) | 1998-10-20 | 1999-10-18 | アルコール依存症、中毒及び乱用の処置に有用な抗痙攣剤誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JP2002527470A (https=) |
| AU (1) | AU759756B2 (https=) |
| BR (1) | BR9914722A (https=) |
| CA (1) | CA2348017C (https=) |
| MX (1) | MXPA01004015A (https=) |
| NO (1) | NO20011901L (https=) |
| NZ (1) | NZ511173A (https=) |
| WO (1) | WO2000023059A2 (https=) |
| ZA (1) | ZA200104037B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
| US6541520B1 (en) | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
| CN100548290C (zh) * | 1999-02-24 | 2009-10-14 | 辛辛那提大学 | 氨基磺酸酯衍生物用于治疗冲动控制障碍的用途 |
| US20020082222A1 (en) | 2000-11-30 | 2002-06-27 | Shapira Nathan Andrew | Treatments for neurogenetic disorders, impulse control disorder, and wound healing |
| US6462084B1 (en) * | 2001-05-14 | 2002-10-08 | Brookhaven Science Associates, Llc | Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US6541520B1 (en) * | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
-
1999
- 1999-10-18 NZ NZ511173A patent/NZ511173A/en unknown
- 1999-10-18 CA CA002348017A patent/CA2348017C/en not_active Expired - Fee Related
- 1999-10-18 BR BR9914722-0A patent/BR9914722A/pt not_active Application Discontinuation
- 1999-10-18 MX MXPA01004015A patent/MXPA01004015A/es not_active Application Discontinuation
- 1999-10-18 AU AU13131/00A patent/AU759756B2/en not_active Ceased
- 1999-10-18 WO PCT/US1999/023769 patent/WO2000023059A2/en not_active Ceased
- 1999-10-18 JP JP2000576834A patent/JP2002527470A/ja active Pending
-
2001
- 2001-04-18 NO NO20011901A patent/NO20011901L/no not_active Application Discontinuation
- 2001-05-17 ZA ZA200104037A patent/ZA200104037B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003521471A5 (https=) | ||
| RU98123607A (ru) | Применение топирамата или его производных для получения лекарственного средства для лечения маниакально-депрессивных биполярных расстройств | |
| RU98123575A (ru) | Способ лечения ожирения и способ индуцирования потери веса у млекопитающих | |
| JP2004505004A5 (https=) | ||
| JP2003528808A5 (https=) | ||
| EP1283054A4 (en) | MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF | |
| EA199600104A1 (ru) | Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты | |
| JP2001525359A5 (https=) | ||
| RU2003100076A (ru) | Противосудорожные производные, используемые для профилактики развития сахарного диабета и синдрома х | |
| BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
| JP2001526218A5 (https=) | ||
| JP2003509349A5 (https=) | ||
| EP0744405A3 (en) | Cyclic peptide antifungal agents | |
| JP2002519425A5 (https=) | ||
| DE69221563D1 (de) | Polyfluoralkylthiopoly(ethylimidazolium)-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als biozide Mittel | |
| CA2426852A1 (en) | Formulation containing phosphate derivatives of electron transfer agents | |
| JP2002527470A5 (https=) | ||
| JP2005512965A5 (https=) | ||
| JP2002536328A5 (https=) | ||
| JP2002522501A5 (https=) | ||
| RU99107566A (ru) | Производные, обладающие противосудорожным действием, пригодные для лечения невропатической боли | |
| JP2005516898A5 (https=) | ||
| KR890014480A (ko) | 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| CA2300289A1 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
| CA2020474A1 (en) | Antiinflammatory and/or antiallergic composition |